ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,269,728 | -49.9% | 400,545 | -21.5% | 0.01% | -50.0% |
Q2 2023 | $2,534,968 | -47.7% | 510,054 | -48.0% | 0.01% | -50.0% |
Q1 2023 | $4,849,440 | -26.2% | 981,668 | -6.0% | 0.02% | -35.1% |
Q4 2022 | $6,568,842 | -22.9% | 1,044,331 | +32.3% | 0.04% | -19.6% |
Q3 2022 | $8,524,000 | -11.4% | 789,273 | -6.5% | 0.05% | -8.0% |
Q2 2022 | $9,620,000 | +33.1% | 843,861 | +6.3% | 0.05% | +22.0% |
Q1 2022 | $7,229,000 | +72.2% | 793,495 | +182.0% | 0.04% | +78.3% |
Q4 2021 | $4,198,000 | +225.4% | 281,386 | +450.8% | 0.02% | +109.1% |
Q4 2020 | $1,290,000 | -70.6% | 51,091 | -56.1% | 0.01% | -70.3% |
Q3 2020 | $4,387,000 | -48.3% | 116,345 | -41.3% | 0.04% | -61.9% |
Q2 2020 | $8,488,000 | – | 198,221 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |